Telestroke at Comprehensive Stroke Center During the COVID-19 Pandemic
NCT04761874 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 296
Last updated 2021-04-22
Summary
TELEstroke to CAre for STroke Patients at a Comprehensive Stroke Center (TELECAST-CSC) during the COVID-19 pandemic is a pre-post study evaluating guideline-based acute ischemic stroke care following the implementation of inpatient telestroke at a comprehensive stroke center during the COVID-19 global pandemic. TELECAST-CSC compares two cohorts: the "in-person phase" (December 1, 2019-March 15, 2020), when all inpatient stroke team care was delivered conventionally in-person and the "telestroke phase" (March 16, 2020-June 29, 2020) when all inpatient stroke team care was delivered exclusively via telestroke as part of our healthcare system's pandemic response. We studied the following primarily clinical endpoints: diagnostic stroke evaluation, secondary stroke prevention, health screening and evaluation, stroke education, mortality, and stroke recurrence and readmission rates.
Conditions
- Stroke, Acute
Interventions
- OTHER
-
Telestroke
In the telestroke cohort, acute ischemic stroke patients at a single comprehensive stroke center received their stroke care and management exclusively via telestroke.
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Christopher Streib, MD · The University of Minnesota
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-12-01
- Primary Completion
- 2020-06-29
- Completion
- 2020-09-29
Countries
- United States
Study Locations
More Related Trials
-
TPA in Acute Stroke With COVID Verus Non-COVID-19 Patients
NCT05258565 ·Status: COMPLETED ·Phase: PHASE1
-
Use of Minocicline in Patients With Stroke
NCT01556802 ·Status: UNKNOWN ·Phase: PHASE1
-
Efficacy and Safety of SP-8203 (Otaplimastat) in Patients With Acute Ischemic Stroke Receiving Thrombolytic Standard of Care
NCT06660719 ·Status: RECRUITING ·Phase: PHASE3
-
Efficacy and Safety of Early Initiation of Butylphthalide Treatment in Patients With Acute Ischemic Stroke.
NCT06472921 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Minocycline on Patients With Ischemic Stroke Undergoing Intravenous Thrombectomy
NCT05487417 ·Status: RECRUITING ·Phase: PHASE4
-
Minocycline Efficacy in Improving Neurological Outcome of Patients Who Undergo Endovascular Revascularization for Acute Ischemic Stroke
NCT05367362 ·Status: WITHDRAWN ·Phase: PHASE2
-
Randomization to Endovascular Treatment Alone or Preceded by Systemic Thrombolysis With Tenecteplase in Ischemic Stroke
NCT05199194 ·Status: RECRUITING ·Phase: PHASE3
-
Endovascular Treatment With Versus Without Intravenous rhTNK-tPA in Stroke
NCT04733742 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Study to Assess the Safety and Effectiveness of the Penumbra System
NCT00334061 ·Status: COMPLETED ·Phase: PHASE2
-
Safety Study of Post Intravenous tPA Monitoring in Ischemic Stroke
NCT02039375 ·Status: COMPLETED ·Phase: NA
-
IMPROVE Stroke Care- Developing and Optimizing Regional Systems of Stroke Care
NCT04242784 ·Status: COMPLETED
-
Promoting Recovery After STroke With Amantadine
NCT05140148 ·Status: RECRUITING ·Phase: PHASE2
-
Tenecteplase in Stroke Patients Between 4.5 and 24 Hours
NCT03785678 ·Status: COMPLETED ·Phase: PHASE3
-
Intensified Secondary Prevention Intending a Reduction of Recurrent Events in TIA and Minor Stroke Patients
NCT01586702 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Minocycline in Patients With Moderate to Severe Acute Ischemic Stroke
NCT05836740 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Nerinetide in Participants With Acute Ischemic Stroke Undergoing Endovascular Thrombectomy Excluding Thrombolysis
NCT04462536 ·Status: COMPLETED ·Phase: PHASE3
-
A Randomized Controlled Trial of TNK-tPA Versus Standard of Care for Minor Ischemic Stroke With Proven Occlusion
NCT02398656 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Preliminary Efficacy Study of SA4503 in Subjects Recovering From Ischemic Stroke
NCT00639249 ·Status: COMPLETED ·Phase: PHASE2
-
MLC1501 Study Assessing Efficacy in STROke Recovery
NCT05046106 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
A Study to Evaluate the Efficacy and Safety of CP-101,606 in Subjects With an Acute Stroke
NCT00073476 ·Status: TERMINATED ·Phase: PHASE2
-
Beta Blockers In Acute Ischemic Stroke
NCT01061190 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
E-Selectin Nasal Spray to Prevent Stroke Recurrence
NCT00012454 ·Status: TERMINATED ·Phase: PHASE2
-
Neuroprotection in Acute Ischemic Stroke
NCT03320018 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Non-immunogenic Staphylokinase in Reperfusion Therapy of Ischemic Stroke in Routine Clinical Practice
NCT05697575 ·Status: RECRUITING
-
Feasibility and Safety of NeuroFlo in Stroke Patients Receiving Tissue Plasminogen Activator
NCT01006993 ·Status: COMPLETED ·Phase: PHASE1